154 related articles for article (PubMed ID: 10513718)
1. Oxaliplatin-induced haemolytic anaemia.
Desrame J; Broustet H; Darodes de Tailly P; Girard D; Saissy JM
Lancet; 1999 Oct; 354(9185):1179-80. PubMed ID: 10513718
[TBL] [Abstract][Full Text] [Related]
2. Two potential mechanisms of oxaliplatin-induced haemolytic anaemia in a single patient.
Hofheinz RD; Nguyen XD; Buchheidt D; Kerowgan M; Hehlmann R; Hochhaus A
Cancer Chemother Pharmacol; 2004 Mar; 53(3):276-7. PubMed ID: 14676977
[TBL] [Abstract][Full Text] [Related]
3. [Acute idiopathic polyneuritis: a potentially fatal neuropathy that is difficult to diagnose in patients receiving oxaliplatin].
Trabut JB; Brezault C; Chaussade S; Lamarque D
Gastroenterol Clin Biol; 2007 Feb; 31(2):198-9. PubMed ID: 17347631
[No Abstract] [Full Text] [Related]
4. Acute immune hematological complication of oxaliplatin. A series of 3 cases.
Garciaz S; Oziel-Taieb S; Dermeche S; Ries P; Vessaud J; Raoul JL
Tumori; 2014; 100(1):e17-9. PubMed ID: 24675502
[TBL] [Abstract][Full Text] [Related]
5. Oxaliplatin-related hyperammonaemic encephalopathy in a patient with colon cancer.
Chang YY; Lin JK; Jiang JK
Colorectal Dis; 2012 Dec; 14(12):e821. PubMed ID: 22330089
[No Abstract] [Full Text] [Related]
6. Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature.
Cobo F; De Celis G; Pereira A; Latorre X; Pujadas J; Albiol S
Anticancer Drugs; 2007 Sep; 18(8):973-6. PubMed ID: 17667605
[TBL] [Abstract][Full Text] [Related]
7. Hepatic veno-occlusive disease after neoadjuvant treatment of colorectal liver metastases with oxaliplatin: a lesson of the month.
Schouten van der Velden AP; Punt CJ; Van Krieken JH; Derleyn VA; Ruers TJ
Eur J Surg Oncol; 2008 Mar; 34(3):353-5. PubMed ID: 17207961
[TBL] [Abstract][Full Text] [Related]
8. A case report of oxaliplatin extravasation.
Foo KF; Michael M; Toner G; Zalcberg J
Ann Oncol; 2003 Jun; 14(6):961-2. PubMed ID: 12796037
[No Abstract] [Full Text] [Related]
9. Anaphylactic reaction to oxaliplatin: a case report.
Larzillière I; Brandissou S; Breton P; Lingoungou A; Gargot D; Ramain JP; Harnois C
Am J Gastroenterol; 1999 Nov; 94(11):3387-8. PubMed ID: 10566767
[No Abstract] [Full Text] [Related]
10. Oxaliplatin-induced Evan's syndrome.
Earle CC; Chen WY; Ryan DP; Mayer RJ
Br J Cancer; 2001 Feb; 84(3):441. PubMed ID: 11161414
[No Abstract] [Full Text] [Related]
11. Sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy.
Seo AN; Kim H
Clin Mol Hepatol; 2014 Mar; 20(1):81-4. PubMed ID: 24757663
[No Abstract] [Full Text] [Related]
12. [Readministration of oxaliplatin using a rapid desensitization method after severe anaphylactic reaction].
Arotçarena R; Berthélémy P; Piot M; Pariente A
Gastroenterol Clin Biol; 2001 Feb; 25(2):206-7. PubMed ID: 11319450
[No Abstract] [Full Text] [Related]
13. Sudden-onset pancytopenia with intracranial hemorrhage after oxaliplatin treatment: a case report and literature review.
Teng CJ; Hsieh YY; Chen KW; Chao TC; Tzeng CH; Wang WS
Jpn J Clin Oncol; 2011 Jan; 41(1):125-9. PubMed ID: 20826449
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin-induced ototoxicity in adjuvant setting for colorectal cancer: unusual side effect.
Hijri FZ; Arifi S; Ouattassi N; Mellas N; El Mesbahi O
J Gastrointest Cancer; 2014 Mar; 45(1):106-8. PubMed ID: 23494572
[No Abstract] [Full Text] [Related]
15. Acute hemolysis after receiving oxaliplatin treatment: a case report and literature review.
Lai JI; Wang WS
Pharm World Sci; 2009 Oct; 31(5):538-541. PubMed ID: 19588266
[TBL] [Abstract][Full Text] [Related]
16. The use cetuximab after oxaliplatin-based chemotherapy in a patient with metastatic colorectal cancer.
Malik Z; Eng C
Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):4-7. PubMed ID: 17491584
[No Abstract] [Full Text] [Related]
17. [Regenerative nodular hyperplasia of the liver related to oxaliplatin-based chemotherapy].
Béchade D; Désolneux G; Fonck M; Soubeyran I; Bécouarn Y; Evrard S
Presse Med; 2013 Jan; 42(1):102-7. PubMed ID: 22770975
[No Abstract] [Full Text] [Related]
18. Splenic artery ligation for severe oxaliplatin induced portal hypertension: a way to improve postoperative course and allow adjuvant chemotherapy for colorectal liver metastases.: Letter to editor: comment about "Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases".
Schwarz L; Faitot F; Soubrane O; Scatton O
Eur J Surg Oncol; 2014 Jun; 40(6):787-8. PubMed ID: 24613742
[No Abstract] [Full Text] [Related]
19. An immediate hemolytic reaction induced by repeated administration of oxaliplatin.
Chen VM; Thrift KM; Morel-Kopp MC; Jackson D; Ward CM; Flower RL
Transfusion; 2004 Jun; 44(6):838-43. PubMed ID: 15157248
[TBL] [Abstract][Full Text] [Related]
20. Sinusoidal obstruction syndrome is a major feature of hepatic lesions associated with oxaliplatin neoadjuvant chemotherapy for liver colorectal metastases.
Rubbia-Brandt L; Mentha G; Terris B
J Am Coll Surg; 2006 Jan; 202(1):199-200. PubMed ID: 16377516
[No Abstract] [Full Text] [Related]
[Next] [New Search]
